Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arya Mariam Roy

Showing results (11-20 of 55) with videos related to

Pageof 6
Sort By:
NEJM Evidence|February 6, 2024
A 47-Year-Old Woman with Confusion and WeaknessArchit Patel, Arya Mariam Roy, Ronald Alberico, et al.
Molecular and Clinical Oncology|March 13, 2023
Immunotherapy in malignant peritoneal mesothelioma (Review)Sabah Alaklabi, Arya Mariam Roy, Joseph J Skitzki, et al.
Exploration of Targeted Anti-Tumor Therapy|January 12, 2024
Facing the conundrum: which first-line therapy should be used for patients with metastatic triple-negative breast cancer carrying germline <i>BRCA</i> mutation?Sabah Alaklabi, Arya Mariam Roy, Lubna N Chaudhary, et al.
Clinical Genitourinary Cancer|July 15, 2020
Neoadjuvant Cabozantinib in Renal-Cell Carcinoma: A Brief ReviewArya Mariam Roy, Andrew Briggler, Danielle Tippit, et al.
Cancer|June 23, 2023
A review of treatment options in HER2-low breast cancer and proposed treatment sequencing algorithmArya Mariam Roy, Vasanthan Muthusamy Kumarasamy, Ajay Dhakal, et al.
Ejhaem|May 7, 2025
Epidemiology, Survival, and Second Primary Malignancies in T-Cell Large Granular Lymphocytic LeukemiaArya Mariam Roy, Sawyer Bawek, Richa Parikh, et al.
Healthcare (Basel, Switzerland)|August 9, 2024
Effects of Immunotherapy on Quality-of-Life Outcomes in Patients with Gastroesophageal Cancers: A Meta-Analysis of Randomized Controlled TrialsKush Gupta, Arya Mariam Roy, Kristopher Attwood, et al.
Pharmacology & Therapeutics|May 3, 2024
The role of lidocaine in cancer progression and patient survivalKohei Chida, Hirofumi Kanazawa, Hirotaka Kinoshita, et al.
Research Square|November 28, 2024
DEPTH2 score was associated with cell proliferation and immune cell infiltrations but not with systemic treatment response in breast cancerKohei Chida, Rongrong Wu, Arya Mariam Roy, et al.
American Journal of Cancer Research|September 11, 2023
Pancreatic ductal adenocarcinoma with a high expression of alcohol dehydrogenase 1B is associated with less aggressive features and a favorable prognosisKohei Chida, Masanori Oshi, Arya Mariam Roy, et al.
Pageof 6

Showing results (11-20 of 55) with videos related to

Sort By:
Pageof 6
NEJM Evidence|February 6, 2024
A 47-Year-Old Woman with Confusion and WeaknessArchit Patel, Arya Mariam Roy, Ronald Alberico, et al.
Molecular and Clinical Oncology|March 13, 2023
Immunotherapy in malignant peritoneal mesothelioma (Review)Sabah Alaklabi, Arya Mariam Roy, Joseph J Skitzki, et al.
Exploration of Targeted Anti-Tumor Therapy|January 12, 2024
Facing the conundrum: which first-line therapy should be used for patients with metastatic triple-negative breast cancer carrying germline <i>BRCA</i> mutation?Sabah Alaklabi, Arya Mariam Roy, Lubna N Chaudhary, et al.
Clinical Genitourinary Cancer|July 15, 2020
Neoadjuvant Cabozantinib in Renal-Cell Carcinoma: A Brief ReviewArya Mariam Roy, Andrew Briggler, Danielle Tippit, et al.
Cancer|June 23, 2023
A review of treatment options in HER2-low breast cancer and proposed treatment sequencing algorithmArya Mariam Roy, Vasanthan Muthusamy Kumarasamy, Ajay Dhakal, et al.
Ejhaem|May 7, 2025
Epidemiology, Survival, and Second Primary Malignancies in T-Cell Large Granular Lymphocytic LeukemiaArya Mariam Roy, Sawyer Bawek, Richa Parikh, et al.
Healthcare (Basel, Switzerland)|August 9, 2024
Effects of Immunotherapy on Quality-of-Life Outcomes in Patients with Gastroesophageal Cancers: A Meta-Analysis of Randomized Controlled TrialsKush Gupta, Arya Mariam Roy, Kristopher Attwood, et al.
Pharmacology & Therapeutics|May 3, 2024
The role of lidocaine in cancer progression and patient survivalKohei Chida, Hirofumi Kanazawa, Hirotaka Kinoshita, et al.
Research Square|November 28, 2024
DEPTH2 score was associated with cell proliferation and immune cell infiltrations but not with systemic treatment response in breast cancerKohei Chida, Rongrong Wu, Arya Mariam Roy, et al.
American Journal of Cancer Research|September 11, 2023
Pancreatic ductal adenocarcinoma with a high expression of alcohol dehydrogenase 1B is associated with less aggressive features and a favorable prognosisKohei Chida, Masanori Oshi, Arya Mariam Roy, et al.
Pageof 6